WASHINGTON, Dec. 3 /PRNewswire/ -- Karen Ignagni, President and CEO of America’s Health Insurance Plans, issued the following statement on the Centers for Medicare and Medicaid Services’ (CMS) draft formulary guidance for organizations offering coverage under the Medicare Prescription Drug Benefit program:
(Logo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGO )
“While we will be reviewing the guidance in greater detail, today CMS has taken the important step of signaling that under the Medicare prescription drug benefit, Medicare beneficiaries should be able to take advantage of proven private plan strategies that are promoting affordable access to clinically sound prescription drug benefits. Health insurance plans have a strong track record of providing cost-effective pharmaceutical benefits that meet consumer needs. Earlier this week, the Center for Studying Health System Change and the Employee Benefit Research Institute released a study that demonstrates recent success of the tools being employed by private-sector insurance plans in mitigating prescription drug spending trends.”
America’s Health Insurance Plans -- Providing health benefits to more than 200 million Americans.
Photo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comAmerica’s Health Insurance Plans
CONTACT: Mohit Ghose of America’s Health Insurance Plans,+1-202-778-8494, or mghose@ahip.net
Web site: http://www.ahip.net/